weiterführende Literatur
(Brandt, Zimmermann et al. 2012, Dorr, Krautwald et al. 2013, Engeholm, Leo-Kottler et al. 2013, Dorr, Ringelstein et al. 2014, Kleffner, Dorr et al. 2014, Ringelstein, Albrecht et al. 2015, Brandt, Oberwahrenbrock et al. 2016, Kleffner, Dorr et al. 2016, Gross, Meyer et al. 2019) Brandt, A. U., T. Oberwahrenbrock, F. Costello, M. Fielden, K. Gertz, I. Kleffner, F. Paul, R. Bergholz and J. Dorr (2016). "Retinal Lesion Evolution in Susac Syndrome." Retina 36(2): 366-374.
(Gross 2019) Gross, C. C., C. Meyer, U. Bhatia, L. Yshii, I. Kleffner, J. Bauer, A. R. Troscher, A. Schulte-Mecklenbeck, S. Herich, T. Schneider-Hohendorf, H. Plate, T. Kuhlmann, M. Schwaninger, W. Bruck, M. Pawlitzki, D. A. Laplaud, D. Loussouarn, J. Parratt, M. Barnett, M. E. Buckland, T. A. Hardy, S. W. Reddel, M. Ringelstein, J. Dorr, B. Wildemann, M. Kraemer, H. Lassmann, R. Hoftberger, E. Beltran, K. Dornmair, N. Schwab, L. Klotz, S. G. Meuth, G. Martin-Blondel, H. Wiendl and R. Liblau (2019). "CD8(+) T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome." Nat Commun 10(1): 5779.
(Kleffner 2016) Kleffner, I., J. Dorr, M. Ringelstein, C. C. Gross, Y. Bockenfeld, W. Schwindt, B. Sundermann, H. Lohmann, H. Wersching, J. Promesberger, N. von Konigsmarck, A. Alex, R. Guthoff, C. J. Frijns, L. J. Kappelle, S. Jarius, B. Wildemann, O. Aktas, F. Paul, H. Wiendl, T. Duning and C. European Susac (2016). "Diagnostic criteria for Susac syndrome." J Neurol Neurosurg Psychiatry 87(12): 1287-1295.
(Ringelstein 2015) Ringelstein, M., P. Albrecht, I. Kleffner, B. Buhn, J. Harmel, A. K. Muller, D. Finis, R. Guthoff, R. Bergholz, T. Duning, M. Kramer, F. Paul, A. Brandt, T. Oberwahrenbrock, J. Mikolajczak, B. Wildemann, S. Jarius, H. P. Hartung, O. Aktas and J. Dorr (2015). "Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography." Neurology 85(7): 610-618.
(Dörr 2014) Dorr, J., M. Ringelstein, T. Duning and I. Kleffner (2014). "Update on Susac syndrome: new insights in brain and retinal imaging and treatment options." J Alzheimers Dis 42 Suppl 3: S99-108.
(Kleffner 2014) Kleffner, I., J. Dorr, T. Duning, P. Young, E. B. Ringelstein and M. Schilling (2014). "Susac syndrome treated with subcutaneous immunoglobulin." Eur Neurol 71(1-2): 89-92.
(Engeholm 2013) Engeholm, M., B. Leo-Kottler, H. Rempp, T. Lindig, H. Lerche, I. Kleffner, M. Henes and M. Dihne (2013). "Encephalopathic Susac's Syndrome associated with livedo racemosa in a young woman before the completion of family planning." BMC Neurol 13: 185.
(Kleffner 2012) Kleffner I, Duning T, Lohmann H, Deppe M, Basel T, Promesberger J, et al. A brief review of Susac syndrome. J Neurol Sci 2012; 322: 35–40.
(Dörr 2011b) Dörr J. [Neuromyelitis optica and Susac-Syndrome – rare but important differential diagnoses of multiple sclerosis]. Nervenheilkunde 2011: 480–486.
(Ringelstein 2010) Ringelstein EB, Kleffner I, Dittrich R, Kuhlenbaumer G, Ritter MA: Hereditary and non-hereditary microangiopathies in the young. An up-date, J Neurol Sci 2010, 299:81-85.
(Rennebohm 2008) Rennebohm RM, Egan Robert A, Susac John O. Treatment of Susac’s Syndrome. Curr Treat Options Neurol 2008; 10: 67–74.
(Susac 2003) Susac J. O., Murtagh FR, Egan R. A., Berger JR, Bakshi R, Lincoff N, et al. MRI findings in Susac’s syndrome. Neurology 2003; 61: 1783–1787.
(Susac 1979) Susac J O, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology 1979; 29: 313–316.